Acorda Therapeutics, Inc. (ACOR)

0.98
0.28 39.00
NASDAQ
Prev Close 0.70
Open 0.70
Day Low/High 0.65 / 0.71
52 Wk Low/High 0.70 / 7.13
Volume 3.43M
Exchange NASDAQ
Shares Outstanding 47.98B
Market Cap 35.28M
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Geron Shares Rise on Fast Track Designation -- Biotech Movers

Geron Shares Rise on Fast Track Designation -- Biotech Movers

The FDA granted fast track designation to imetelstat as a potential treatment for adults with with transfusion-dependent anemia.

Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports

Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports

A guide to keep track of all the companies reporting first quarter financial results today -- making sense of what's important and disregarding what's not.

Acorda upgraded at Goldman

Acorda Therapeutics Stock Surges on Clinical Trial Results

Acorda Therapeutics Stock Surges on Clinical Trial Results

Acorda Therapeutics announced positive results in a clinical trial for its drug CVT-301.

Chart Trends in Airgas, Acorda Therapeutics

Chart Trends in Airgas, Acorda Therapeutics

Weekly support allows time for daily recoveries.

Accorda upgraded at FBR

Acorda Therapeutics upgraded at MKM

FDA More Problematic Than Obamacare, Says Acorda CEO

FDA More Problematic Than Obamacare, Says Acorda CEO

Ron Cohen, CEO of Acorda Therapeutics, says his company's pipeline is full and he is less worried about Obamacare than the FDA.

Acorda downgraded at JP Morgan